Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CTP synthase 1 is an enzyme encoded by the *CTPS1* gene and plays a crucial role in the de novo synthesis of cytidine triphosphate (CTP), a key nucleotide for DNA, RNA, and phospholipid biosynthesis. It is essential for the proliferation of T cells, making it a promising target for immunosuppressive therapies and treatments of lymphocyte cancers. CTPS1 is an asymmetrical homotetramer with three catalytically active monomers. It utilizes ATP, UTP, and glutamine for enzymatic activity. CTPS1 is up-regulated in activated lymphocytes, contributing to increased CTP pools necessary for cell proliferation. It is less sensitive to CTP feedback inhibition compared to CTPS2, allowing sustained activity in proliferating cells. Selective inhibition of CTPS1 is a promising strategy for treating autoimmune diseases and lymphocyte cancers while minimizing off-target effects.
Inhibition of CTP synthesis, mimicking CTP binding sites to halt nucleotide production
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CTP synthase 1 (CTPS1).